Key statistics
On Monday, X4 Pharmaceuticals Inc (XFOR:NAQ) closed at 3.55, 162.96% above the 52 week low of 1.35 set on Aug 11, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.57 |
|---|---|
| High | 3.63 |
| Low | 3.53 |
| Bid | -- |
| Offer | -- |
| Previous close | 3.56 |
| Average volume | 437.68k |
|---|---|
| Shares outstanding | 87.44m |
| Free float | 80.52m |
| P/E (TTM) | -- |
| Market cap | 310.40m USD |
| EPS (TTM) | -10.50 USD |
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
Announcements
- X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference
- X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
- X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
- X4 Pharmaceuticals Announces Proposed Underwritten Public Offering
- X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
More ▼
